HIV PEP using a 3-drug regimen
If a 3-drug regimen is indicated for HIV postexposure prophylaxis in adults and children 16 years or older, add to any of the above regimens:
1dolutegravir 50 mg orally, daily for 4 weeks. For dosage adjustment in adults with kidney impairment, see dolutegravir dosage adjustment dolutegravir dolutegravir dolutegravir
OR
1raltegravir 1200 mg orally, daily for 4 weeks. For dosage adjustment in adults with kidney impairment, see raltegravir dosage adjustment. raltegravir raltegravir raltegravir
If there is exposure to drug-resistant HIV or if adverse effects of the above regimens limit their use, seek expert advice.